ALERIZON®

Oral solution, 0.5mg/ml
RxActive license

Active substance (INN)

desloratadine

Pharmaceutical form

Pharmaceutical formOral solution
Strength0.5mg/ml
PackagingUkupno 1 bočica staklena sa 60ml oralnog rastvora u kartonskoj kutiji
ManufacturerStada Arzneimittel AG, Germany
Therapeutic groupRespiratory system (R06AX27)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateJanuary 27, 2021

Analogs in Montenegro

6

Other medicines with the same active substance

Source: CInMED register